{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantity:
Pancragen (Synthetic Peptide Bioregulator)
• What it is: A synthetic tetrapeptide with the amino acid sequence Lys-Glu-Asp-Trp (KEDW), belonging to the Khavinson family of short, tissue-specific peptide bioregulators.
• Origin: Originally derived from bovine pancreatic cells.
• Proposed Mechanism: It is studied for its ability to interact with cellular DNA and histones to influence gene expression and protein synthesis in pancreatic cells (both insulin-producing islet cells and enzyme-producing acinar cells).
• Regulatory Status: Not FDA-approved and not an approved medication for diabetes, pancreatitis, or any medical condition. It is sold strictly as a research-only compound. Self-treating with unapproved peptides carries significant health and safety risks.